NCT04736433View on ClinicalTrials.gov

Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.

CompletedOBSERVATIONAL
Enrollment

6,066

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
Heart Failure
Interventions
DRUG

ACE inhibitor

ACE inhibitor dispensing claim is used as the reference

DRUG

Sacubitril/Valsartan

Sacubitril/Valsartan dispensing claim is used as the reference

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04736433 - Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data. | Biotech Hunter | Biotech Hunter